Livongo Health Inc

Founded in 2008, Livongo is a health care company based in California. It is focused on supporting patients across the USA with chronic illnesses, such as diabetes and hypertension. The firm aims to empower people managing chronic conditions to live longer, happier, healthier lives. Livongo also specialises in behavioural health, providing support for patients dealing with depression, anxiety, stress, and sleep disorders. Products and services offered include smart devices for health monitoring, expert coaching and interactive health programmes. The company trades on the NASDAQ with the ticker LVGO. At launch in July 2019, LVGO stock opened at $40.51 per share, showing a premium of almost 45% over its IPO price. By the end of its first day of trading, Livongo was valued at $3.4bn. The LVGO price chart shows a 52-week high of $150.00 and a 52-week low of $15.12, as of August 2020, with a market cap of $11.72bn. The company serves more than 328,000 members, with numbers growing at 100% annually, and provides four of the seven most extensive health plans. The company’s strategy of supporting customers in tracking, monitoring and managing chronic conditions is backed by data-driven research. That work results in measurable and sustainable clinical outcomes. Track this instrument via your eToro watchlist for more updates and news on the current LVGO share value.